Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

PIEZO1 activation delays erythroid differentiation of normal and Hereditary Xerocytosis-derived human progenitors.

Caulier A, Jankovsky N, Demont Y, Ouled-Haddou H, Demagny J, Guitton C, Merlusca L, Lebon D, Vong P, Aubry A, Lahary A, Rose C, Gréaume S, Cardon E, Platon J, Ouadid-Ahidouch H, Rochette J, Marolleau JP, Picard V, Garçon L.

Haematologica. 2019 Aug 14. pii: haematol.2019.218503. doi: 10.3324/haematol.2019.218503. [Epub ahead of print]

2.

TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism.

Brigant B, Metzinger-Le Meuth V, Rochette J, Metzinger L.

Int J Mol Sci. 2018 Dec 24;20(1). pii: E67. doi: 10.3390/ijms20010067. Review.

3.
4.

Protect the neglected half of our blue planet.

Wright G, Rochette J, Gjerde KM, Levin LA.

Nature. 2018 Feb 8;554(7691):163-165. doi: 10.1038/d41586-018-01594-1. No abstract available.

PMID:
29420492
5.

New intragenic rearrangements in non-Finnish mulibrey nanism.

Jobic F, Morin G, Vincent-Delorme C, Cadet E, Cabry R, Mathieu-Dramard M, Copin H, Rochette J, Jedraszak G.

Am J Med Genet A. 2017 Oct;173(10):2782-2788. doi: 10.1002/ajmg.a.38381. Epub 2017 Aug 17.

PMID:
28815877
6.

Carbamoylmethylphosphine Oxide-Functionalized MIL-101(Cr) as Highly Selective Uranium Adsorbent.

De Decker J, Rochette J, De Clercq J, Florek J, Van Der Voort P.

Anal Chem. 2017 Jun 6;89(11):5678-5682. doi: 10.1021/acs.analchem.7b00821. Epub 2017 May 9.

PMID:
28485957
7.

Nitrate Controls Root Development through Posttranscriptional Regulation of the NRT1.1/NPF6.3 Transporter/Sensor.

Bouguyon E, Perrine-Walker F, Pervent M, Rochette J, Cuesta C, Benkova E, Martinière A, Bach L, Krouk G, Gojon A, Nacry P.

Plant Physiol. 2016 Oct;172(2):1237-1248. Epub 2016 Aug 19.

8.

A New Intergenic α-Globin Deletion (α-αΔ125) Found in a Kabyle Population.

Singh AR, Lacan P, Cadet E, Bignet P, Dumesnil C, Vannier JP, Joly P, Rochette J.

Hemoglobin. 2016;40(2):108-12. doi: 10.3109/03630269.2015.1136640.

PMID:
26911300
9.

Growth hormone deficiency and pituitary malformation in a recurrent Cat-Eye syndrome: a family report.

Jedraszak G, Braun K, Receveur A, Decamp M, Andrieux J, Rabbind Singh A, Copin H, Bremond-Gignac D, Mathieu M, Rochette J, Morin G.

Ann Endocrinol (Paris). 2015 Oct;76(5):629-34. doi: 10.1016/j.ando.2015.02.002. Epub 2015 Oct 27.

PMID:
26518262
10.

OCEANOGRAPHY. Contrasting futures for ocean and society from different anthropogenic CO₂ emissions scenarios.

Gattuso JP, Magnan A, Billé R, Cheung WW, Howes EL, Joos F, Allemand D, Bopp L, Cooley SR, Eakin CM, Hoegh-Guldberg O, Kelly RP, Pörtner HO, Rogers AD, Baxter JM, Laffoley D, Osborn D, Rankovic A, Rochette J, Sumaila UR, Treyer S, Turley C.

Science. 2015 Jul 3;349(6243):aac4722. doi: 10.1126/science.aac4722. Review.

11.

[Cat eye syndrome].

Bremond-Gignac D, Morin G, Jedraszak G, Receveur A, Rochette J, Copin H.

J Fr Ophtalmol. 2015 Apr;38(4):368-9. doi: 10.1016/j.jfo.2014.09.016. Epub 2015 Mar 20. French. No abstract available.

12.

Stormorken syndrome or York platelet syndrome: A clinician's dilemma.

Singh AR, Morin G, Rochette J.

Mol Genet Metab Rep. 2015 Jan 29;2:80. doi: 10.1016/j.ymgmr.2015.01.003. eCollection 2015 Mar. No abstract available.

13.

Severe phenotypic spectrum of biallelic mutations in PRRT2 gene.

Delcourt M, Riant F, Mancini J, Milh M, Navarro V, Roze E, Humbertclaude V, Korff C, Des Portes V, Szepetowski P, Doummar D, Echenne B, Quintin S, Leboucq N, Singh Amrathlal R, Rochette J, Roubertie A.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):782-5. doi: 10.1136/jnnp-2014-309025. Epub 2015 Jan 16.

PMID:
25595153
14.

Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways.

Anbazhagan K, Rabbind Singh A, Isabelle P, Stella I, Céline AD, Bissac E, Bertrand B, Rémy N, Naomi T, Vincent F, Rochette J, Lassoued K.

Immun Inflamm Dis. 2013 Oct;1(1):26-36. doi: 10.1002/iid3.4. Epub 2013 Oct 30.

15.

Gain-of-Function Mutation in STIM1 (P.R304W) Is Associated with Stormorken Syndrome.

Morin G, Bruechle NO, Singh AR, Knopp C, Jedraszak G, Elbracht M, Brémond-Gignac D, Hartmann K, Sevestre H, Deutz P, Hérent D, Nürnberg P, Roméo B, Konrad K, Mathieu-Dramard M, Oldenburg J, Bourges-Petit E, Shen Y, Zerres K, Ouadid-Ahidouch H, Rochette J.

Hum Mutat. 2014 Oct;35(10):1221-32. doi: 10.1002/humu.22621.

PMID:
25044882
16.

Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients.

Callebaut I, Joubrel R, Pissard S, Kannengiesser C, Gérolami V, Ged C, Cadet E, Cartault F, Ka C, Gourlaouen I, Gourhant L, Oudin C, Goossens M, Grandchamp B, De Verneuil H, Rochette J, Férec C, Le Gac G.

Hum Mol Genet. 2014 Sep 1;23(17):4479-90. doi: 10.1093/hmg/ddu160. Epub 2014 Apr 8.

PMID:
24714983
17.

Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes.

Maïga RI, Bonnaure G, Rochette JT, Néron S.

J Immunol Res. 2014;2014:635108. doi: 10.1155/2014/635108. Epub 2014 Dec 23.

18.

Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.

Coppo P, Henry-Dessailly I, Rochette J, Lok C, Buendia B, Lassoued K.

Eur J Intern Med. 2013 Dec;24(8):868-71. doi: 10.1016/j.ejim.2013.06.013. Epub 2013 Oct 31.

PMID:
24184038
19.

A severe prenatal presentation of Cat Eye Syndrome.

Jedraszak G, Receveur A, Andrieux J, Naepels P, Mathieu-Dramard M, Bremond-Gignac D, Sevestre H, Copin H, Rochette J.

Clin Dysmorphol. 2013 Oct;22(4):175-7. doi: 10.1097/MCD.0000000000000011. No abstract available.

PMID:
23982124
20.

Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies.

Cézard C, Rabbind Singh A, Le Gac G, Gourlaouen I, Ferec C, Rochette J.

Blood Cells Mol Dis. 2014 Jan;52(1):27-34. doi: 10.1016/j.bcmd.2013.07.011. Epub 2013 Aug 14.

PMID:
23953397
21.

Atom transfer radical polymerization preparation and photophysical properties of polypyridylruthenium derivatized polystyrenes.

Fang Z, Ito A, Keinan S, Chen Z, Watson Z, Rochette J, Kanai Y, Taylor D, Schanze KS, Meyer TJ.

Inorg Chem. 2013 Aug 5;52(15):8511-20. doi: 10.1021/ic400520m. Epub 2013 Jul 16.

PMID:
23859706
22.

Dual phenotypic transmission in Brugada syndrome.

Hermida JS, Arnalsteen-Dassonvalle E, Kubala M, Mathiron A, Traulle S, Anbazhagan K, Hermida A, Rochette J.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):366-72. doi: 10.1016/j.acvd.2013.04.007. Epub 2013 Jun 28.

23.

PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine.

Cloarec R, Bruneau N, Rudolf G, Massacrier A, Salmi M, Bataillard M, Boulay C, Caraballo R, Fejerman N, Genton P, Hirsch E, Hunter A, Lesca G, Motte J, Roubertie A, Sanlaville D, Wong SW, Fu YH, Rochette J, Ptácek LJ, Szepetowski P.

Neurology. 2012 Nov 20;79(21):2097-103. doi: 10.1212/WNL.0b013e3182752c46. Epub 2012 Oct 17.

24.

Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.

Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohammed S, Müller U, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu YH, Ptáček LJ.

Cell Rep. 2012 Jan 26;1(1):2-12. doi: 10.1016/j.celrep.2011.11.001. Epub 2011 Dec 15.

25.

Avoiding the "no".

Rochette J.

Can Vet J. 2011 Dec;52(12):1361-2. No abstract available.

26.

[Molecular diagnosis of HFE mutations in routine laboratories. Results of a survey from reference laboratories in France].

Jouanolle AM, Gérolami V, Ged C, Grandchamp B, Le Gac G, Pissard S, Rochette J, Aguilar-Martinez P.

Ann Biol Clin (Paris). 2012 May-Jun;70(3):305-13. doi: 10.1684/abc.2012.0704. French.

27.

Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.

Green L, De Lord C, Clark B, Cadet E, Rochette J, Thein SL.

Br J Haematol. 2011 Aug;154(3):288. doi: 10.1111/j.1365-2141.2011.08666.x. Epub 2011 Apr 27. No abstract available.

PMID:
21521183
28.

Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, Lassoued K, Schved JF, Rochette J.

Haematologica. 2011 Apr;96(4):507-14. doi: 10.3324/haematol.2010.029751. Epub 2011 Jan 12.

29.

Prospective evaluation of the familial prevalence of the brugada syndrome.

Hermida JS, Dassonvalle E, Six I, Amant C, Coviaux F, Clerc J, Herent D, Hermida A, Rochette J, Jarry G.

Am J Cardiol. 2010 Dec 15;106(12):1758-62. doi: 10.1016/j.amjcard.2010.07.049.

PMID:
21126620
30.

Infantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11.

Roll P, Sanlaville D, Cillario J, Labalme A, Bruneau N, Massacrier A, Délepine M, Dessen P, Lazar V, Robaglia-Schlupp A, Lesca G, Jouve E, Rudolf G, Rochette J, Lathrop GM, Szepetowski P.

PLoS One. 2010 Oct 29;5(10):e13750. doi: 10.1371/journal.pone.0013750.

31.

Novel familial cases of ICCA (infantile convulsions with paroxysmal choreoathetosis) syndrome.

Rochette J, Roll P, Fu YH, Lemoing AG, Royer B, Roubertie A, Berquin P, Motte J, Wong SW, Hunter A, Robaglia-Schlupp A, Ptacek LJ, Szepetowski P.

Epileptic Disord. 2010 Sep;12(3):199-204. doi: 10.1684/epd.2010.0328. Epub 2010 Aug 17.

32.

[Flowcharts for the diagnosis and the molecular characterization of hemoglobinopathies].

Aguilar-Martinez P, Badens C, Bonello-Palot N, Cadet E, Couque N, Ducrocq R, Elion J, Francina A, Joly P, Pissard S, Rochette J; Réseay DHOS Pathologie héréditaire de l'érythrocyte.

Ann Biol Clin (Paris). 2010 Jul-Aug;68(4):455-64. doi: 10.1684/abc.2010.0457. French.

33.

Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Rochette J, Le Gac G, Lassoued K, Férec C, Robson KJ.

Hum Genet. 2010 Sep;128(3):233-48. doi: 10.1007/s00439-010-0852-1. Epub 2010 Jul 6. Review.

PMID:
20607553
34.

First identification of a point mutation at position -83 (G>A) of the beta-globin gene promoter.

Cadet E, Foulon K, Claisse JF, Rochette J.

Hemoglobin. 2009;33(3):274-8. doi: 10.1080/03630260903081323.

PMID:
19657844
35.

Human insulin A-chain peptide analog(s) with in vitro biological activity.

Le Flem G, Pecher J, Le Flem-Bonhomme V, Withdrawn A, Rochette J, Pujol JP, Bogdanowicz P.

Cell Biochem Funct. 2009 Aug;27(6):370-7. doi: 10.1002/cbf.1584.

PMID:
19618407
36.

Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.

Jouannaud V, Cadranel JF, Dumouchel P, Cazier A, Capron D, Rochette J, Barbare JC.

Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1310-3. doi: 10.1097/MEG.0b013e3283221112.

PMID:
19478679
37.

A novel HFE mutation (c.del478) results in nonsense-mediated decay of the mutant transcript in a hemochromatosis patient.

Pointon JJ, Lok CY, Shearman JD, Suckling RJ, Rochette J, Merryweather-Clarke AT, Robson KJ.

Blood Cells Mol Dis. 2009 Sep-Oct;43(2):194-8. doi: 10.1016/j.bcmd.2009.04.007. Epub 2009 May 24.

PMID:
19477142
38.

Genetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes.

Rochette J, Roll P, Szepetowski P.

J Med Genet. 2008 Dec;45(12):773-9. doi: 10.1136/jmg.2008.059519. Review.

PMID:
19047496
39.

An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]+[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1.

Dupradeau FY, Pissard S, Coulhon MP, Cadet E, Foulon K, Fourcade C, Goossens M, Case DA, Rochette J.

Hum Mutat. 2008 Jan;29(1):206.

PMID:
18157833
40.

A novel beta-Thalassemic allele due to a two nucleotide deletion: beta76 (-GC).

Foulon K, Rochette J, Cadet E.

Hemoglobin. 2007;31(1):31-7.

PMID:
17365003
41.

Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl.

Aguilar-Martinez P, Lok CY, Cunat S, Cadet E, Robson K, Rochette J.

Haematologica. 2007 Mar;92(3):421-2.

42.

Type III collagen mimetic peptides designed with anti- or pro-aggregant activities on human platelets.

Pires V, Pêcher J, Da Nascimento S, Maurice P, Bonnefoy A, Dassonville A, Amant C, Fauvel-Lafève F, Legrand C, Rochette J, Sonnet P.

Eur J Med Chem. 2007 May;42(5):694-701. Epub 2007 Jan 12.

PMID:
17316914
43.

Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes.

Pires VS, Gaboriau F, Guillon J, Nascimento S, Dassonville A, Lescoat G, Desplat V, Rochette J, Jarry C, Sonnet P.

J Enzyme Inhib Med Chem. 2006 Jun;21(3):261-70.

PMID:
16918073
44.

Functionalization of multiwalled carbon nanotubes by mild aqueous sonication.

Yang DQ, Rochette JF, Sacher E.

J Phys Chem B. 2005 Apr 28;109(16):7788-94.

PMID:
16851905
45.
46.

Implementing a pressure ulcer prevention program and enhancing the role of the CWOCN: impact on outcomes.

Hiser B, Rochette J, Philbin S, Lowerhouse N, Terburgh C, Pietsch C.

Ostomy Wound Manage. 2006 Feb;52(2):48-59.

47.

[Screening for HFE C282Y mutation at birth?].

Rochette J, Cadet E.

Rev Med Interne. 2006 Jan;27(1):1-4. Epub 2005 Nov 22. French. No abstract available.

PMID:
16337066
48.

Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse.

Maurice P, Pires V, Amant C, Kauskot A, Da Nascimento S, Sonnet P, Rochette J, Legrand C, Fauvel-Lafeve F, Bonnefoy A.

Vascul Pharmacol. 2006 Jan;44(1):42-9. Epub 2005 Nov 2.

PMID:
16269270
49.

PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.

Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F, Sevestre H, Krimpenfort P, Corsini A, Rochette J, Glineur C, Fruchart JC, Torpier G, Staels B.

J Clin Invest. 2005 Nov;115(11):3228-38.

50.

The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts).

Maurice P, Waeckel L, Pires V, Sonnet P, Lemesle M, Arbeille B, Vassy J, Rochette J, Legrand C, Fauvel-Lafève F.

Histochem Cell Biol. 2006 Apr;125(4):407-17. Epub 2005 Oct 5.

PMID:
16205938

Supplemental Content

Loading ...
Support Center